Skip to main content
. 2021 Feb 9;117(9):2016–2029. doi: 10.1093/cvr/cvab038

Figure 7.

Figure 7

Therapeutic potential of phosphate inhibitors for cardiovascular mineralization. Examples of phosphate binders, bisphosphonates and inositol hexaphosphates and their effects on the absorption and resorption of inorganic phosphate (Pi), as well as on hydroxyapatite (HAP) deposition and growth during valvular and vascular mineralization.